The woodchuck hepatitis B virus infection model for the evaluation of HBV therapies and vaccine therapies.
about
Regulatory Forum Opinion Piece*: Use and Utility of Animal Models of Disease for Nonclinical Safety Assessment: A Pharmaceutical Industry Survey.Woodchuck hepatitis virus core gene deletions and proliferative responses of peripheral blood mononuclear cells stimulated by an immunodominant epitope: a viral immune escape in the woodchuck model of chronic hepatitis B?
P2860
The woodchuck hepatitis B virus infection model for the evaluation of HBV therapies and vaccine therapies.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
The woodchuck hepatitis B viru ...... erapies and vaccine therapies.
@en
The woodchuck hepatitis B viru ...... erapies and vaccine therapies.
@nl
type
label
The woodchuck hepatitis B viru ...... erapies and vaccine therapies.
@en
The woodchuck hepatitis B viru ...... erapies and vaccine therapies.
@nl
prefLabel
The woodchuck hepatitis B viru ...... erapies and vaccine therapies.
@en
The woodchuck hepatitis B viru ...... erapies and vaccine therapies.
@nl
P2093
P2860
P1476
The woodchuck hepatitis B viru ...... erapies and vaccine therapies.
@en
P2093
Andrea Canitano
Claudio Argentini
Emilio D'Ugo
Roberto Giuseppetti
Stefania Catone
P2860
P304
P356
10.1517/17460441.2010.530252
P407
P577
2010-12-01T00:00:00Z